Tigecycline

Overview

Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic . The mean inhibitory concentration (MIC) of Tigecycline for E. coli (MG1655 strain) is approximately 125 ng/mL. MIC 50 and MIC 90 are 1 and 2 mg/L for Acinetobacter baumannii ( A. baumannii ), respectively.

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Autophagy | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Antibiotic

Product Information

• Catalog No.: HY-B0117
• CAS No.: 220620-09-7
• Molecular Formula: C29H39N5O8
• Molecular Weight: 585.65
• Purity: 99.95%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.27 mM); Clear solution
• Availability: In-stock

Source

Original product source